IC

Ikarian Capital Portfolio holdings

AUM $773M
1-Year Est. Return 443.74%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+443.74%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$200M
AUM Growth
-$40.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
142
New
Increased
Reduced
Closed

Top Buys

1
+$12.2M
2
+$10.6M
3
+$7.73M
4
SAGE
Sage Therapeutics
SAGE
+$6.1M
5
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$5.3M

Top Sells

1
+$12.7M
2
+$11.3M
3
+$11.1M
4
UTHR icon
United Therapeutics
UTHR
+$9.43M
5
CLDX icon
Celldex Therapeutics
CLDX
+$6.76M

Sector Composition

1 Healthcare 98.33%
2 Consumer Staples 0%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$2.93M 1.46%
+23,131
27
$2.93M 1.46%
10,962
+9,840
28
$2.7M 1.35%
+100,000
29
$2.43M 1.21%
162,766
-87,234
30
$1.86M 0.93%
16,809
-8,191
31
$1.72M 0.86%
6,874
-73
32
$1.48M 0.74%
+45,100
33
$1.26M 0.63%
463,156
-372,119
34
$1.19M 0.59%
85,200
-19,800
35
$1.16M 0.58%
+200,000
36
$1.1M 0.55%
+265,000
37
$973K 0.49%
18,954
-37,038
38
$843K 0.42%
6,566
-20,465
39
$839K 0.42%
12,662
-4,233
40
$815K 0.41%
136,059
-517,389
41
$725K 0.36%
288,119
-5,164
42
$612K 0.31%
61,474
-5,552
43
$612K 0.31%
221,830
-140,707
44
$560K 0.28%
2,800
-58,437
45
$558K 0.28%
188,664
-69,189
46
$556K 0.28%
260,087
-62,130
47
$537K 0.27%
448,101
-75,247
48
$521K 0.26%
15,582
-2,978
49
$490K 0.24%
49,031
-108,159
50
$437K 0.22%
156,203
-24,996
1
2
3 4 5